Mersana Therapeutics, Inc.: accounts_payable
| Value | {"amount": 2067000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2016-12-31) |
| Status | superseded |
| Entity | Mersana Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:14:28.455098+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3e84ce36-3182-45e7-94e2-9c9edc66b934
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-17-006537Retrieved: 2026-08-19T14:14:28.455098+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001442836/accounts-payable/2016-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3e84ce36-3182-45e7-94e2-9c9edc66b934
History
- no predecessors — first report